This inventor holds 1 USPTO granted patent. Top assignees: Carnegie Mellon University, University of Illinois. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,188 
1 out of 2,430 
Years Active: 2017
Title: Amynah Pradhan: Innovator in Pain Management and Neuropsychiatric Disorders
Introduction
Amynah Pradhan is a distinguished inventor based in Chicago, IL (US). She has made significant contributions to the field of pain management and neuropsychiatric disorders through her innovative research and patented methods. Her work focuses on enhancing the bioavailability of the delta-opioid receptor, which has important implications for treating various neurological conditions.
Latest Patents
Amynah Pradhan holds a patent for a method to increase the bioavailability of the delta-opioid receptor for the management of pain and neuropsychiatric disorders. This patent describes a method to induce surface trafficking of the delta-opioid receptor (DOR) and its applications. The method leverages the antinociceptive potential of DOR agonists to treat neurological disorders and serve as analgesics without the adverse consequences typically associated with chronic treatment by mu-opioid receptor (MOR) agonists. The patent also includes screening compounds to identify additional targets for stimulated DOR delivery. She has 1 patent to her name.
Career Highlights
Throughout her career, Amynah has worked with prestigious institutions such as Carnegie Mellon University and the University of Illinois. Her research has garnered attention for its potential to revolutionize pain management and improve the quality of life for individuals suffering from neuropsychiatric disorders.
Collaborations
Amynah has collaborated with notable colleagues, including Daniel J. Shiwarski and Manojkumar A. Puthenveedu. These collaborations have further enriched her research and contributed to the advancement of her innovative methods.
Conclusion
Amynah Pradhan is a pioneering inventor whose work in enhancing the bioavailability of the delta-opioid receptor holds promise for the future of pain management and neuropsychiatric treatment. Her contributions to the field are invaluable and continue to inspire further research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile